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Sterolsa b s t r a c t
Oxysterols are oxidised forms of cholesterol that are intermediates in the synthesis of bile acids and
steroid hormones. They are also ligands to nuclear and G protein-coupled receptors. Analysis of oxyster-
ols in biological systems is challenging due to their low abundance coupled with their lack of a strong
chromophore and poor ionisation characteristics in mass spectrometry (MS). We have previously used
enzyme-assisted derivatisation for sterol analysis (EADSA) to identify and quantitate oxysterols in biolog-
ical samples. This technique relies on tagging sterols with the Girard P reagent to introduce a charged
quaternary ammonium group. Here, we have compared several modiﬁed Girard-like reagents and show
that the permanent charge is vital for efﬁcient MSn fragmentation. However, we ﬁnd that the reagent can
be extended to include sites for potential stable isotope labels without a loss of performance.
 2014 The Authors. Published by Elsevier Inc. Open access under CC BY license.1. Introduction
Oxysterols are neutral lipids formed by oxidation of cholesterol
either by enzymatic oxidation (especially by enzymes of the cyto-
chrome P450 family) or by autoxidation. As well as acting as key
components of the bile acid biosynthesis pathways [1], oxysterols
have been shown to bind to liver X receptors (LXRs) [2,3], retinoic
acid related orphan receptors (RORs) [4] and the G protein-coupled
receptor Epstein–Barr virus induced gene 2 (EBI2) [5,6]. Very re-
cently (25R)26-hydroxycholesterol has been shown to promote
proliferation of breast cancer cell lines by binding to the estrogen
receptor (ER) a [7,8].
Sterols are typically under-represented in global lipidomics
studies which are dominated by charged species (e.g. phospholip-
ids) or those readily ionised due to the presence of a functional
group such as an amine (e.g. sphingosine, sphingomyelin). Thesterolome itself is dominated by cholesterol which is present at a
level three orders of magnitude higher than the most abundant
oxysterols. In addition, the lack of a strong chromophore and poor
ionisation characteristics in mass spectrometry (MS) make the
analysis and accurate quantitation of oxysterols challenging. Gas
chromatography (GC)–MS with prior derivatisation to trimethyl-
silyl ethers is considered the ‘gold standard’ for oxysterol analysis
but a number of liquid chromatography (LC)–MS approaches have
also been reported (for a recent review see Ref. [9]).
Chemical derivatisation is commonly used in LC–MS methods
to improve the ionisation characteristics of the biological mole-
cules of interest [10]. An effective derivatisation reagent should:
(1) react in near-quantitative yield with the analyte of interest
(e.g. by ‘click’ chemistry [11]); (2) incorporate a permanently
charged or readily ionised functional group (e.g. an amine); and
preferably (3) be amenable to stable-isotope labelling for use in
relative and absolute quantitation experiments.
We have developed an LC–electrospray ionisation (ESI)–MS
method including enzyme-assisted derivatisation for sterol (or ste-
roid) analysis (EADSA) [12]. Sterols are enzymatically oxidised
using bacterial cholesterol oxidase before ‘charge-tagging’ with
the Girard P (GP) reagent (Fig. 1A). This incorporates a permanently
charged quaternary ammonium group which increases solubility
in reversed-phase solvents, improves ionisation by several orders
of magnitude, and directs fragmentation of the sterol backbone
to provide structurally informative MSn (MS with multistage frag-
mentation) spectra.
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Fig. 1. (A) Numbering of the cholesterol backbone and outline of EADSA exempliﬁed with 24S-hydroxycholesterol. (B) Novel derivatisation reagents 2–7 used in this study.
CHO: cholesterol oxidase; GP: Girard P.
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agent (Crick et al., manuscript in preparation [13,14]) we have syn-
thesised and tested a range of charge tags incorporating a variety of
functional groups. Here we evaluate the performance of these re-
agents and discuss their merits and limitations.
2. Materials and methods
A list of the sources of reagents and equipment along with a de-
tailed protocol for EADSA is given in Ref. [12].
2.1. Solvents and reagents
HPLC grade solvents were from Fisher Scientiﬁc (Loughborough,
UK). GP reagent (1-(carboxymethyl)pyridinium chloride hydra-
zide) was from TCI Europe (Oxford, UK) and 2-(1-piperidinyl)acet-
ohydrazide was from Fluorochem (Hadﬁeld, UK). Phenylacetic
hydrazide and cholesterol oxidase from Streptomyces sp. were from
Sigma–Aldrich (Dorset, UK). Certiﬁed Sep-Pak tC18 200 mg and
Oasis HLB 60 mg cartridges were fromWaters (Elstree, UK). Pooled
serum from male AB plasma was from Sigma–Aldrich. Chemicals
used for the synthesis of derivatisation reagents 4–7 were from
Sigma–Aldrich.
2.2. Synthesis of derivatisation reagents
Charge tags were synthesised using a modiﬁcation of the proce-
dure reported by Girard and Sandulesco [15]. A solution of hetero-
cycle (4-dimethylaminopyridine, 4-pyrollopyridine, isoquinoline
or 4-phenylpyridine, 12.6 mmol) and ethyl bromoacetate (1.4 mL,
12.6 mmol) in absolute ethanol (10 mL) was heated at reﬂux for
4 h. The mixture was slowly cooled to 0 C and hydrazine hydrate
(788 lL of 78–80% solution in H2O, 12.6 mmol) was added drop-
wise. The resulting white precipitate was recovered by ﬁltration
and dried under reduced pressure to afford the desired derivatisa-
tion reagent (4, 5, 6 or 7) in 80–95% yield.
2.3. Extraction of oxysterols from serum
Serum (100 lL) was added dropwise to a solution of 24(R/S)-
[25,26,26,26,27,27,27-2H7] hydroxycholesterol (20 ng) in absolute
ethanol (1.05 mL total volume) in an ultrasound bath. After
5 min, water (350 lL) was added, ultrasonicated for a further
5 min then centrifuged at 14,000g for 30 min at 4 C. A WatersSep-Pak tC18 cartridge was rinsed with 4 mL of absolute ethanol
followed by 6 mL of 70% ethanol and the serum in 70% ethanol
(1.5 mL) was applied to the column. The ﬂow-through was col-
lected and combined with a wash of 5.5 mL of 70% ethanol to give
SPE-1-Fr-1 containing oxysterols. The cartridge was washed with a
further 4 mL of 70% ethanol to give SPE-1-Fr-2, before cholesterol
was eluted with 2 mL of absolute ethanol (SPE-1-Fr-3). Finally,
the column was washed with 2 mL of absolute ethanol to give
SPE-1-Fr-4. The fraction containing oxysterols (SPE-1-Fr-1) was
dried under reduced pressure using a vacuum concentrator.
2.4. Enzyme-assisted derivatisation
The dried fractions were reconstituted in 100 lL propan-2-ol
and 1 mL potassium phosphate buffer (50 mM, pH 7) containing
3 lL of cholesterol oxidase (2 mg/mL H2O, 44 U/mg protein) was
added. The mixture was incubated at 37 C for 1 h when the reac-
tion was stopped by addition of methanol (2 mL). Acetic acid
(150 lL) was added followed by 0.8 mmol of the derivatisation re-
agent to be tested. The mixture was vortexed until all of the solid
was dissolved then incubated at room temperature overnight in
the dark.
2.5. Removal of excess reagent
To remove excess reagent while retaining all of the compounds
of interest, a recycling procedure was used. The procedure is sim-
ilar to that previously reported [12] but a Waters Oasis HLB 60 mg
cartridge was used in place of the Sep-Pak tC18.
An Oasis HLB cartridge was pre-conditioned with methanol
(6 mL), 10% methanol (6 mL) and ﬁnally 70% methanol (4 mL).
The reaction mixture (in 3 mL 70% methanol) was loaded onto
the cartridge and the ﬂow-through collected. The column was
washed with 70% methanol (1 mL) followed by 35% methanol
(1 mL). Water (4 mL) was added to the combined eluent to give
9 mL 35% methanol. This solution was applied to the same car-
tridge and the ﬂow-through collected, along with a wash of 17%
methanol (1 mL). Water (9 mL) was added to the eluent to give
19 mL 17% methanol. This solution was applied to the column
followed by a wash of 10% methanol (6 mL). Finally, the oxysterols
were eluted from the cartridge using methanol (3  1 mL) then
ethanol (1 mL) to give SPE-2-Fr-1, Fr-2, Fr-3 and Fr-4. Aliquots of
SPE-2-Fr-1 and Fr-2 were combined and diluted to 60% methanol
for analysis by LC–MS.
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Separation of oxysterols was performed on an UltiMate 3000
HPLC system (Dionex) using a Phenomonex Kinetex C18 column
(50  2.1 mm, 1.7 lm particles). Mobile phase A consisted of
33.3% methanol, 16.7% acetonitrile, 50% water and 0.1% formic
acid. Mobile phase B consisted of 63.3% methanol, 31.7% acetoni-
trile, 5% water and 0.1% formic acid. The ﬂow rate was 200 lL/
min. The gradient started at 20% mobile phase B for 1 min before
rising to 80% mobile phase B over the next 7 min. After a further100
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HCA derivatised with piperidine reagent 2 (554? 469?).5 min the gradient returned to 20% mobile phase B over 6 s before
re-equilibration for 3 min 54 s to give a total run time of 17 min.
The eluent was directed to the atmospheric pressure ionisation
(API) source of an LTQ-Orbitrap Velos (Thermo Fisher, San Jose,
CA, USA). 35 lL of the mixture to be analysed was injected onto
the column and a targeted multiple reaction monitoring (MRM)-
like method was used to fragment ions of interest in the linear
ion trap (LIT), e.g. m/z 548? 469? for 3b-hydroxycholest-5-
en-(25R)-26-oic acid (3b-HCA) derivatised with GP reagent. The
collision energy was 30 units for the MS2 step and 35 units for6.07
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Orbitrap over the m/z range 400–610 at 30,000 resolution (FWHM
deﬁnition).
3. Results and discussion
3.1. Derivatisation with the GP reagent enhances oxysterol analysis by
MS and MSn
Derivatisation with a reagent possessing an amine moiety is a
common technique to enhance the ionisation of analytes of inter-
est in ESI–MS [10]. Primary, secondary and tertiary amines are all100
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sodiated adducts, while quaternary ammonium species carry a
permanent positive charge to typically give a strong response in
positive mode ESI–MS. We have previously used the GP reagent
1 to introduce a quaternary ammonium moiety to sterols to en-
hance detection by LC–ESI–MS (EADSA, Fig. 1A).
To assess the importance of the permanent charge we deriva-
tised a commercially available pooled serum sample with reagent
2 (incorporating a piperidine) and reagent 3 (incorporating a phe-
nyl ring) in parallel with the GP reagent (Fig. 1B). Fig. 2A shows
reconstructed ion chromatograms (RICs) plotted on the same
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at a level of approximately 80 ng/mL and gives a high-intensity
peak when derivatised with the GP reagent (Fig. 2A, top panel).
We found that derivatisation with piperidine (reagent 2) gave a
peak corresponding to the protonated adduct with an intensity
similar to that of the GP reagent (Fig. 2A, middle panel). The sodi-
ated adduct was present at a level of less than 10% of this peak.
Therefore, in MS mode, a tertiary amine results in a similar gain
in sensitivity as a quaternary ammonium. However, we were un-
able to identify a peak corresponding to 3b-HCA derivatised with
phenyl reagent 3 as either the protonated or sodiated adduct
(Fig. 2A, bottom panel). Similar results were obtained for other
analytes from the same serum sample.
The sterol backbone is made up almost exclusively of carbon–
carbon and carbon–hydrogen bonds plus a carbon–oxygen bond.
This makes MS2 experiments on underivatised molecules difﬁcult
as, in a typical experiment, the fragmentation spectrum is domi-
nated by the non-speciﬁc loss of a molecule of water. A key feature
of EADSA is a characteristic and predictable loss of pyridine (79 Da)
from the GP tag in MS2. Importantly, loss of 79 Da is not a com-
monly observed neutral loss from other biomolecules. In addition,
this pathway results in transfer of the positive charge from the der-
ivatising group to the sterol backbone, which can then be frag-
mented further to afford structurally informative fragments in
MS3 spectra. Fragmentation of GP-derivatised 3b-HCA results in a
major transition ofm/z 548? 469 corresponding to the loss of pyr-
idine (Fig. 2B, top panel and C). A less intense peak is also observed
at m/z 441 assigned to a loss of pyridine along with a molecule of
carbon monoxide. However, fragmentation of 3b-HCA derivatised
with piperidine reagent 2 gives no signiﬁcant peak in the equiva-
lent chromatogram (Fig. 2B, lower panel) although a similar (but
weak) fragmentation spectrum can be identiﬁed at 6.55 min
(Fig. 2D). Further activation of the fragment at m/z 469 gives an
MS3 spectrum with peaks corresponding to fragmentation of the
sterol A/B-rings (m/z 151, 163), the residual derivatising group
and carboxylate group (m/z 408, 423, 441, 451). Again, the inten-
sity is considerably higher (thirty fold) for 3b-HCA derivatised with
the GP reagent (Fig. 2E) compared with derivatisation using piper-
idine reagent 2 (Fig. 2F). The weak fragmentation of sterols deriva-
tised with reagent 2 would be of particular importance to
techniques that rely exclusively on MS2 for identiﬁcation and
quantitation, for example SRM or MRM carried out on a triple-
quadrupole mass spectrometer.
3.2. The GP reagent can be modiﬁed without a loss in performance
Derivatisation reagents may be isotopically labelled to be used
in relative and absolute quantiﬁcation experiments. For example,
the TMT and iTRAQ reagents used in proteomics experiments allow
the simultaneous quantiﬁcation of up to 6 samples in a single ana-
lytical run [16]. In a similar manner, incorporating stable-isotope
labels in the GP reagent will allow the analysis of multiple serum
samples in a single LC–ESI–MS injection. However, the relatively
small size of the GP reagent limits the number of isotope labels that
can be included. If the size of the reagent could be extendedwithout
a loss of performance, isotope labels could be incorporated at more
positions to increase the utility of this strategy. We have synthes-
ised a library of modiﬁed Girard reagents incorporating heterocy-
cles larger than pyridine. For example, 4-dimethylaminopyridine
(4-DMAP) can be used to obtain reagent 4 (Fig. 1B) which possesses
an additional dimethylamino group. This gives the potential for the
introduction of two isotopically coded methyl groups (e.g. CD3 in
place of CH3) thus increasing the scope for multiplexing.
In a similar fashion, incorporation of 4-pyrollopyridine, isoquin-
oline, or 4-phenylpyridine gives reagents 5–7, again with
additional sites for potential isotope labelling (Fig. 1B). All of thesyntheses are straightforward and high yielding (typically 80–
95%) and can be carried out on large scales (10 g). The reagents
are obtained as white solids that can be used immediately without
the need for time consuming puriﬁcation steps.
To compare the performance of reagents 4–7 a commercially
available pooled serum sample was derivatised with each charge
tag along with the GP reagent. As above, we compared the intensi-
ties of the peaks corresponding to 3b-HCA. The four new reagents
give a similar MS response to that of the GP reagent suggesting that
the dominant factor in determining ionisation efﬁciency is the
presence of a quaternary ammonium ion (Fig. 3A, note the chro-
matograms are plotted on the same y-axis). Modiﬁcations to the
reagent can be used to ‘tune’ the retention time of analytes of
interest; for example an additional ring at the 4 position increases
the retention time by around 1 min (Fig. 3A, compare top left panel
with bottom left and bottom right one). Such modiﬁcations could
be useful for the analysis of polar molecules that are poorly re-
tained on reversed-phase columns.
Oxysterols derivatised with reagents 4–7 fragment in a similar
way to those tagged with the GP reagent. In the case of 3b-HCA,
neutral loss of the heterocyclic portion of the charge tag gives
the same fragment at m/z 469 which can again be fragmented fur-
ther to give an MS3 spectrum similar to that obtained from the GP
reagent (Fig. 3B–E). Incorporation of an amine at the 4 position of
the heterocycle (i.e. using 4-DMAP or 4-pyrollopyridine) lowers
the efﬁciency of the MS3 fragmentation by a factor of ﬁve. How-
ever, structurally informative fragments are still observed allowing
conﬁdent identiﬁcation of the analytes of interest.
In conclusion we have shown that the GP reagent can be mod-
iﬁed without a loss of performance. Replacing the quaternary
ammonium moiety with a tertiary amine does not affect ionisation
in the ESI–MS mode but greatly reduces the efﬁciency of MS2 frag-
mentation, thus removing a key beneﬁt of EADSA. However,
replacing pyridine with other heterocycles in the GP reagent does
not signiﬁcantly affect the performance of the reagent, giving the
potential for future synthesis of multiplexed series of isotopically
labelled tags.
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